Integra Lifesciences Holdings Corp (IART)

Operating Cash Flow (Statement)

$22.80M

Quarterly · Period ending: · USD

IART logo

IART Operating Cash Flow (Statement)

Latest reported$22.80M
IART Quarterly Cash from Operations (-$1.20M → $22.80M)
High-resolution chart · PNG

IART operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Integra Lifesciences Holdings Corp Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-1,566,000
4,550,000
-1,463,000
1,596,000
-3,833,000
-1,260,000
1,500,000
-600,000
4,300,000
-2,700,000
-3,000,000
-2,100,000
-2,600,000
-2,100,000
-4,100,000
-1,500,000
-1,100,000
-1,200,000
-2,100,000
-1,400,000
-2,400,000
-2,100,000
-1,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.